These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 20977428)
1. Effects of YC-1 targeting hypoxia-inducible factor 1 alpha in oesophageal squamous carcinoma cell line Eca109 cells. Feng Y; Zhu H; Ling T; Hao B; Zhang G; Shi R Cell Biol Int; 2011 May; 35(5):491-7. PubMed ID: 20977428 [TBL] [Abstract][Full Text] [Related]
2. Effects of YC-1 on hypoxia-inducible factor 1 alpha in hypoxic human bladder transitional carcinoma cell line T24 cells. Li Y; Zhao X; Tang H; Zhong Z; Zhang L; Xu R; Li S; Wang Y Urol Int; 2012; 88(1):95-101. PubMed ID: 22041818 [TBL] [Abstract][Full Text] [Related]
3. [Impact of RNA interference targeting hypoxia-inducible factor-1alpha on chemosensitivity in esophageal squamous cell carcinoma cells under hypoxia]. Wu XA; Sun Y; Fan QX; Wang LX; Wang RL; Zhang L Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(37):2640-4. PubMed ID: 18162154 [TBL] [Abstract][Full Text] [Related]
4. Effects of YC-1 on hypoxia-inducible factor 1-driven transcription activity, cell proliferative vitality, and apoptosis in hypoxic human pancreatic cancer cells. Zhao Q; Du J; Gu H; Teng X; Zhang Q; Qin H; Liu N Pancreas; 2007 Mar; 34(2):242-7. PubMed ID: 17312464 [TBL] [Abstract][Full Text] [Related]
5. Preclinical evaluation of YC-1, a HIF inhibitor, for the prevention of tumor spreading. Shin DH; Kim JH; Jung YJ; Kim KE; Jeong JM; Chun YS; Park JW Cancer Lett; 2007 Sep; 255(1):107-16. PubMed ID: 17502124 [TBL] [Abstract][Full Text] [Related]
6. A domain responsible for HIF-1alpha degradation by YC-1, a novel anticancer agent. Kim HL; Yeo EJ; Chun YS; Park JW Int J Oncol; 2006 Jul; 29(1):255-60. PubMed ID: 16773207 [TBL] [Abstract][Full Text] [Related]
7. [Inhibitory effect of YC-1 on induction of VEGF and GPI genes in hypoxic human pancreatic cancer cells]. Du J; Zhao Q; Gu H; Teng XL; Qin H; Liu NZ Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):486-9. PubMed ID: 17147109 [TBL] [Abstract][Full Text] [Related]
8. Modulating the hypoxia-inducible factor signaling pathway as a therapeutic modality to regulate retinal angiogenesis. DeNiro M; Alsmadi O; Al-Mohanna F Exp Eye Res; 2009 Nov; 89(5):700-17. PubMed ID: 19580810 [TBL] [Abstract][Full Text] [Related]
9. YC-1 inhibits HIF-1 expression in prostate cancer cells: contribution of Akt/NF-kappaB signaling to HIF-1alpha accumulation during hypoxia. Sun HL; Liu YN; Huang YT; Pan SL; Huang DY; Guh JH; Lee FY; Kuo SC; Teng CM Oncogene; 2007 Jun; 26(27):3941-51. PubMed ID: 17213816 [TBL] [Abstract][Full Text] [Related]
10. [Effect of RNA interference targeting HIF-1α gene on biological behavior of human esophageal squamous cell carcinoma and gastric adenocarcinoma cells in vitro]. Zeng KF; Jin HL; Zhang WF; Xiao B; Zhu H; Hao B; Shi RH Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):260-4. PubMed ID: 21575495 [TBL] [Abstract][Full Text] [Related]
11. Cyclin-dependent kinase inhibitor, P276-00, inhibits HIF-1α and induces G2/M arrest under hypoxia in prostate cancer cells. Manohar SM; Padgaonkar AA; Jalota-Badhwar A; Rao SV; Joshi KS Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):15-27. PubMed ID: 22083267 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of cell growth and up-regulation of MAD2 in human oesophageal squamous cell carcinoma after treatment with the Src/Abl inhibitor dasatinib. Wang L; Guo B; Wang R; Jiang Y; Qin S; Liang S; Zhao Y; Guo W; Li K; Fan X Clin Sci (Lond); 2012 Jan; 122(1):13-24. PubMed ID: 21751967 [TBL] [Abstract][Full Text] [Related]
13. Expression of hypoxia-inducible factor (HIF)-1alpha is associated with vascular endothelial growth factor expression and tumour angiogenesis in human oesophageal squamous cell carcinoma. Kimura S; Kitadai Y; Tanaka S; Kuwai T; Hihara J; Yoshida K; Toge T; Chayama K Eur J Cancer; 2004 Aug; 40(12):1904-12. PubMed ID: 15288294 [TBL] [Abstract][Full Text] [Related]
14. HIF-1α induces VE-cadherin expression and modulates vasculogenic mimicry in esophageal carcinoma cells. Tang NN; Zhu H; Zhang HJ; Zhang WF; Jin HL; Wang L; Wang P; He GJ; Hao B; Shi RH World J Gastroenterol; 2014 Dec; 20(47):17894-904. PubMed ID: 25548487 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of hypoxia inducible factor 1α expression suppresses the progression of esophageal squamous cell carcinoma. Zhu H; Feng Y; Zhang J; Zhou X; Hao B; Zhang G; Shi R Cancer Biol Ther; 2011 Jun; 11(11):981-7. PubMed ID: 21519196 [TBL] [Abstract][Full Text] [Related]
16. Suppression of hypoxia inducible factor-1alpha (HIF-1alpha) by YC-1 is dependent on murine double minute 2 (Mdm2). Lau CK; Yang ZF; Lam CT; Tam KH; Poon RT; Fan ST Biochem Biophys Res Commun; 2006 Oct; 348(4):1443-8. PubMed ID: 16919599 [TBL] [Abstract][Full Text] [Related]
17. [Effect of HIF-1α and its mechanism on invasion and metastasis of esophageal carcinoma Eca109 cells in vitro and in vivo]. Jing SW; Wang YD; Zheng MM; Sun GG; Liu Q; Cheng YJ; Yang CR Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Jan; 28(1):67-71. PubMed ID: 22230507 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of hypoxia-induced increase of blood-brain barrier permeability by YC-1 through the antagonism of HIF-1alpha accumulation and VEGF expression. Yeh WL; Lu DY; Lin CJ; Liou HC; Fu WM Mol Pharmacol; 2007 Aug; 72(2):440-9. PubMed ID: 17513385 [TBL] [Abstract][Full Text] [Related]
19. Blockade of hypoxia-inducible factor-1α by YC-1 attenuates interferon-γ and tumor necrosis factor-α-induced intestinal epithelial barrier dysfunction. Liu H; Li M; Wang P; Wang F Cytokine; 2011 Dec; 56(3):581-8. PubMed ID: 21890376 [TBL] [Abstract][Full Text] [Related]
20. [Expression of hypoxia-inducible factor-1alpha and vessel endothelial growth factor in esophageal squamous cell carcinoma and clinico-pathological significance thereof]. Yu ZT; Zhao HF; Shang XB Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(35):2465-9. PubMed ID: 19080625 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]